NCT02306161-D2
Dataset Information
Dataset ID: NCT02306161-D2
PubMed ID (PMID):
Publication Title:
Randomized Phase 3 Trial of Ganitumab Added to Interval Compressed Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma: A Report from the Children’s Oncology Group
Description of Dataset:
D2: There are 5 datasets associated with the PMID 36669140: NCT02306161-D1 through NCT02306161-D5. This dataset, NCT02306161-D2, provides the information for table 2: toxicity incidence (non-hematologic toxicities occurring in 10% or greater fraction of patients and toxicities of interest regardless of incidence). There is a row per patient, toxicity term, grade, and experienced-toxicity (yes or no).
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
NCT Trial Number | Disease Type |
---|---|
NCT02306161 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®